Hyrimoz and Abdominal distension - a phase IV clinical study of FDA data

Summary:

Abdominal distension is reported as a side effect among people who take Hyrimoz (adalimumab-adaz), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Aspirin, and have Crohn's disease.

The phase IV clinical study analyzes which people have Abdominal distension when taking Hyrimoz. It is created by eHealthMe based on reports of 4,629 people who have side effects when taking Hyrimoz from the FDA, and is updated regularly.

What is Hyrimoz?

Hyrimoz has active ingredients of adalimumab-adaz. eHealthMe is studying from 4,635 Hyrimoz users. Check the latest studies of Hyrimoz.

What is Abdominal distension?

Abdominal distension is found to be associated with 2,550 drugs and 3,658 conditions by eHealthMe. Check the latest studies of Abdominal distension.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

4,629 people reported to have side effects when taking Hyrimoz.
Among them, 53 people (1.14%) have Abdominal distension.

Could Hyrimoz cause Abdominal distension?

Among these 53 people:

How long have people been on Hyrimoz when they have Abdominal distension? *

What is the gender of people who have Abdominal distension when taking Hyrimoz? *

female: 62 %
male: 38 %

What is the age of people who have Abdominal distension when taking Hyrimoz? *

What are other drugs people take besides Hyrimoz? *

What are other side effects people have besides Abdominal distension? *

Abdominal Pain: 27 people, 50.94%
Diarrhea: 18 people, 33.96%
Fatigue (feeling of tiredness): 18 people, 33.96%
Haematochezia (passage of stools containing blood): 16 people, 30.19%
Joint Pain: 14 people, 26.42%
Constipation: 14 people, 26.42%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 14 people, 26.42%
Abdominal Pain Upper: 13 people, 24.53%
Headache (pain in head): 9 people, 16.98%
Injection Site Pain: 9 people, 16.98%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 35 people, 66.04%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 5 people, 9.43%
Psoriasis (immune-mediated disease that affects the skin): 5 people, 9.43%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 7.55%
High Blood Pressure: 3 people, 5.66%
Stress And Anxiety: 2 people, 3.77%
Behcet's Syndrome (involves inflammation of the blood vessels): 2 people, 3.77%
Depression: 2 people, 3.77%
Gastric Ulcer (stomach ulcer): 2 people, 3.77%
Hypersensitivity: 2 people, 3.77%

* Approximation only. Some reports may have incomplete information.

Do you take Hyrimoz and have Abdominal distension?

- Check whether Abdominal distension is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hyrimoz:

Hyrimoz (4,635 reports)

Browse all side effects of Hyrimoz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal distension:

Abdominal distension (2,550 drugs)

Browse all the conditions that are associated with Abdominal distension:

Abdominal distension (3,658 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on adalimumab-adaz (the active ingredients of Hyrimoz) and Hyrimoz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.